MENDRA
Live / Applied — New application — not yet assigned to an examiner (as of 18 Feb 2026)
What this means for you
Not registered yet, but its 18 Feb 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99658639
- Mark type
- Stylized text
- Filed
- 18 Feb 2026
- Attorney of record
- Mark A. Jansen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances; therapeutic and prophylactic pharmaceutical products; medicines for the treatment and prevention of rare diseases, autoimmune diseases, inflammatory diseases, and infectious diseases and disorders; pharmaceutical products for use in medical research and clinical development; pharmaceutical products in development for regulatory approval
- Class 009 — Scientific and electric apparatus: downloadable artificial intelligence software for use with rare diseases; downloadable artificial intelligence software for use in the field of medicine and medical research; downloadable artificial intelligence (AI) software for use in pharmaceutical research, drug discovery, clinical development, regulatory analysis, data analysis, and commercialization; downloadable software for collecting, analyzing, searching, and managing biomedical, clinical, and scientific data; downloadable software platforms for identifying, evaluating, and developing pharmaceutical and therapeutic assets, including software for rare disease research; downloadable software for identifying and recruiting clinical trial participants; downloadable software for managing global regulatory submissions and market access data; downloadable software for mapping and forecasting rare disease populations; downloadable software for facilitating real-time collaboration in pharmaceutical development and commercialization; downloadable artificial intelligence software for developing treatments and drugs for treating rare diseases
- Class 042 — Scientific and technological services: Scientific research and development services in the fields of pharmaceuticals, therapeutics, and medicine; research and development of pharmaceutical products, therapies, and treatments; biomedical research services; pharmaceutical research and clinical development services; providing online non-downloadable software artificial intelligence software for use with rare diseases; providing online non-downloadable software artificial intelligence software for use in the field of medicine and medical research; providing online non-downloadable software artificial intelligence (AI) software for use in pharmaceutical research, drug discovery, clinical development, regulatory analysis, data analysis, and commercialization; providing online non-downloadable software for collecting, analyzing, searching, and managing biomedical, clinical, and scientific data; providing online non-downloadable software for identifying, evaluating, and developing pharmaceutical and therapeutic assets, including software for rare disease research; providing non-downloadable artificial intelligence software for use in pharmaceutical research, rare disease analysis, asset evaluation, clinical development, and commercialization; providing online non-downloadable software for searching, aggregating, analyzing, and modeling biomedical, clinical, and pharmaceutical data; providing temporary use of online, non-downloadable software for identifying and recruiting clinical trial participants; providing temporary use of online, non-downloadable software for managing global regulatory submissions and market access data; providing temporary use of online, non-downloadable software for mapping and forecasting rare disease populations; providing temporary use of online, non-downloadable software for facilitating real-time collaboration in pharmaceutical development and commercialization; providing temporary use of online, non-downloadable artificial intelligence software for developing treatments and drugs for treating rare diseases
- Class 044 — Medical, beauty and agricultural services: Medical research and development services; providing medical and scientific information in the field of rare diseases; providing health and medical information relating to diseases, disorders, diagnosis, treatment, and prevention; medical advisory services relating to pharmaceutical research and development; Consulting services in the field of rare disease drug development; Prevention, diagnostics, treatment, and therapy for rare diseases
Owner
- Mendra, Inc., San Francisco, CA, US
Prosecution history
- 18 Feb 2026 — APPLICATION FILING RECEIPT MAILED
- 18 Feb 2026 — NEW APPLICATION ENTERED